In a retrospective case series investigating osteopenic neonates (<1,000 g), Moreira et al. (49) concluded that elevated PTH serum levels may be a useful marker in identifying low birth weight neonates at risk for MBD. This evidence concerns the gene PTH and Marchiafava-Bignami disease.